Label (083 71)
Topiramate
Product Images NDC 12634-083
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 12634-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical-structure (Chemical Structure)
Figure-1 (Figure 1)
The text describes a figure showing the Kaplan-Meier estimates of cumulative rates for Time to First Seizure. The figure includes two groups of participants, one group taking 50mg/day of topiramate, and another taking 400mg/day of topiramate. The time is evaluated in days, and the data suggests a statistically significant difference between the two groups.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
